Abstract
We have entered a new era in HIV prevention whereby priorities have expanded from biomedical discovery to include implementation, effectiveness, and the effect of combination prevention at the population level. However, gaps in knowledge and implementation challenges remain. In this Review we analyse trends in the rapidly changing landscape of HIV prevention, and chart a new path for HIV prevention research that focuses on the implementation of effective and efficient combination prevention strategies to turn the tide on the HIV pandemic.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Review
MeSH terms
-
AIDS Vaccines / administration & dosage*
-
Acquired Immunodeficiency Syndrome / prevention & control
-
Administration, Oral
-
Anti-HIV Agents / administration & dosage
-
Anti-HIV Agents / therapeutic use*
-
Anti-Retroviral Agents / therapeutic use
-
Circumcision, Male*
-
Female
-
Global Health
-
HIV Infections / diagnosis
-
HIV Infections / epidemiology
-
HIV Infections / prevention & control*
-
HIV Reverse Transcriptase / antagonists & inhibitors
-
HIV Seropositivity / epidemiology
-
Health Services Research* / methods
-
Health Services Research* / standards
-
Health Services Research* / trends
-
Humans
-
Infectious Disease Transmission, Vertical / prevention & control*
-
Male
-
Mass Screening*
-
Primary Prevention* / methods
-
Primary Prevention* / standards
-
Primary Prevention* / trends
-
Research / trends
Substances
-
AIDS Vaccines
-
Anti-HIV Agents
-
Anti-Retroviral Agents
-
HIV Reverse Transcriptase